Tecnovatica S.A. (WSE:TEC)

Market Cap	7.52M +41.1%
Revenue (ttm)	n/a
Net Income	70.15K
EPS	n/a
Shares Out	10.75M
PE Ratio	107.25
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,186
Open	0.7020
Previous Close	0.6780
Day's Range	0.6620 - 0.7040
52-Week Range	0.2280 - 0.8560
Beta	0.40
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Tecnovatica

Tecnovatica S.A. engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets. Its areas of activity are NIPT prenatal diagnostics, genetic cancer diagnostics, artificial intelligence in diagnostics, telemedicine and mobile applications, medical marijuana and supportive therapies, and translational medicine and scientific cooperation. The company was formerly known as Vinci Gen S.A. and changed its name to Tecnovatica S.A. in ...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2010
• Employees: 1
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: TEC